Search by Drug Name or NDC
NDC 42571-0394-89 NICARDIPINE HYDROCHLORIDE 2.5 mg/mL Details
NICARDIPINE HYDROCHLORIDE 2.5 mg/mL
NICARDIPINE HYDROCHLORIDE is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Micro Labs Limited. The primary component is NICARDIPINE HYDROCHLORIDE.
Product Information
| NDC | 42571-0394 |
|---|---|
| Product ID | 42571-394_007019a4-32ef-56c9-e063-6294a90a7bbd |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | NICARDIPINE HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | NICARDIPINE HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 2.5 |
| Active Ingredient Units | mg/mL |
| Substance Name | NICARDIPINE HYDROCHLORIDE |
| Labeler Name | Micro Labs Limited |
| Pharmaceutical Class | Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA216420 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 42571-0394-89 (42571039489)
| NDC Package Code | 42571-394-89 |
|---|---|
| Billing NDC | 42571039489 |
| Package | 10 VIAL in 1 CARTON (42571-394-89) / 10 mL in 1 VIAL (42571-394-88) |
| Marketing Start Date | 2023-11-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |